MARINUS
MRNSDrugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ganaxolone | Phase 3 | Epilepsies, Partial | - | - |
IV Ganaxolone active | Phase 2 | Status Epilepticus | - | - |
Frequently asked questions
What is in MARINUS's drug pipeline?→
CatalystAlert tracks 2 drug candidates in MARINUS's (MRNS) pipeline across Phase 3, Phase 2. Its lead program is ganaxolone (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is MARINUS's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for MARINUS (MRNS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track MRNS biotech catalysts?→
Add MRNS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MARINUS's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.